Premium
Principles of chemotherapy
Author(s) -
Lundqvist Elisabeth Åvall
Publication year - 2012
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(12)60028-9
Subject(s) - medicine , citation , library science , family medicine , computer science
Chemotherapy plays a major role in the treatment of patients with gynecological malignancies. In general, chemotherapy has a smaller therapeutic window compared with drugs of other types; hence, the potential for severe adverse effects associated with chemotherapy has made appropriate patient and drug selection critical. Before initiating treatment of any patient with a chemotherapeutic agent, the following issues should be considered: Tumor characteristics: • The primary malignant diagnosis should be verified histologically. • The first recurrence should be verified preferably by cytology or histology. (Ideally, recurrent disease should be verified by cytology or preferably histology; it is acknowledged that this is not always possible especially in ovarian cancer.) • The extent of disease. • The likelihood of tumor response (e.g. type of cancer, rate of disease progression). Patient characteristics: • The patient’s age. • The patient’s general state of health (performance status). • Comorbidities (such as heart, liver, and kidney diseases). • Previous cancer treatments (response and adverse effects). • The patient’s psychosocial status. Goals of treatment: • Cure • Tumor control to prolong survival. • Palliation of symptoms.